HB2787 HFLR Page 1
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
HOUSE OF REPRESENTATIVES - FLOOR VERSION
STATE OF OKLAHOMA
1st Session of the 59th Legislature (2023)
HOUSE BILL 2787 By: Stinson of the House
and
Rogers of the Senate
AS INTRODUCED
An Act relating to stem cell research; amendi ng 63
O.S. 2021, Section 1-270.2, which relates to
reporting system; removing certain information
collection and reporting duties of the State
Department of Health; and providing an effective
date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLA HOMA:
SECTION 1. AMENDATORY 63 O.S. 20 21, Section 1-270.2, is
amended to read as follows:
Section 1-270.2 A. For the purposes of the Advancement in Stem
Cell Cures and Therapies Act, "human embryo" means a living organism
of the species Homo sapiens at the earliest stage of development ,
including the single-cell stage, that is not located in the body of
a woman.
HB2787 HFLR Page 2
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. Research on human tissue regeneration and human diseases
using adult stem cells and stem cells obtained from umbili cal cord
blood and amniotic fluid may be conducted in this state , provided
that the research is performed:
1. Safely and ethica lly;
2. Only on embryonic stem cell lines created prior to August 1,
2001, and in accordance with federal law as it existed on November
1, 2007; and
3. Without the use of a human embryo , including a human embryo
produced using cloning technology.
C. When research is performed in accordance with the
Advancement in Stem Cell Cures and Therapies Act, a person or
governmental body shall not:
1. Restrict public funds de signated for the stem cell research;
or
2. Obstruct or provide disincentives for the stem cell
research.
D. The State Department of Health shall est ablish a reporting
system that collects information regarding all ac tivities carried
out in accordance wit h this section.
E. The Department shall submit a r eport with all information
collected pursuant to subsection D of this section to the Governor,
the Speaker of the Oklahoma House of Representatives, and the
HB2787 HFLR Page 3
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
President Pro Tempore of the State Senate no lat er than December 31
of each year.
SECTION 2. This act shall become effect ive November 1, 2023.
COMMITTEE REPORT BY: COMMITTEE ON PUBLIC HEALTH, dated 02/16/2023 -
DO PASS, As Coauthored.